Casodex Articles
ZENECA REPORTS ANTICANCER SUCCESSES
19 April 1993
TENORMIN DRAGS DOWN ZENECA AS IT DEMERGES
8 March 1993
ZENECA FILES 1ST NDA FOR MERREM
4 January 1993
ZENECA'S PROMISING R&D PIPELINE PRESENTED
14 December 1992
ANALYST R&D UPDATE FROM ICI
6 January 1992
- Novo Nordisk's diabetes drug Victoza produced 8% weight loss in Ph III obesity trial
- Proposal to list Roche's Neulastim and Actemra in New Zealand
- Alchemia and Merck Serono collaborate on HA-Irinotecan with Erbitux
- Positive new data on Novartis' Galvus in elderly type 2 diabetes patients
- Johnson & Johnson expects 10 NDA filings by 2017, saying pharma sector poised for growth
